News
Cell Biosciences Launches New Platform for Multiplex Western Blot Detection
Cell Biosciences, Inc., a provider of innovative protein analysis tools to life science researchers, announced the launch of the latest addition to their premier...
Press Releases
KOMBIGLYZE XR Tablets, a New Treatment for Type 2 Diabetes Mellitus in Adults, Now Available in U.S. Pharmacies
Bristol-Myers Squibb Company and AstraZeneca announced that KOMBIGLYZE XR (saxagliptin and metformin HCl extended-release), approved by the U.S. Food and Drug Administration (FDA) on...
News
FDA extend review timeline for vandetanib new drug application
AstraZeneca announced that the US Food and Drug Administration (FDA) has extended the time to complete its review of the New Drug Application (NDA)...
News
Daxas (Roflumilast) included as a new treatment option in latest international COPD guidelines
The Global Initiative for Chronic Obstructive Lung Disease (GOLD) has included roflumilast (Daxas®) as a new treatment option in its COPD management guidelines. A...
Press Releases
NovaBay Pharmaceuticals Reports Activity of Aganocide NVC-422 Against Deadly Superbug
NovaBay Pharmaceuticals, a clinical stage biotechnology company developing first-in-class, anti-infective compounds for the treatment and prevention of antibiotic-resistant infections, announces that in tests conducted...
Research Insight
Ardea Biosciences Announces Positive Top-Line Results from Phase 2b Combination Study
Ardea Biosciences, Inc. announced positive, preliminary, top-line results from its Phase 2b study of RDEA594 in combination with the current standard of care for...
News
Merck to Hold Fourth-Quarter 2010 Sales and Earnings Conference Call on Feb. 3
Merck will hold its fourth-quarter 2010 sales and earnings conference call with institutional investors and analysts beginning at 8 a.m. EST on Thursday, Feb....
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read